References and Notes
1a
Narimatsu S.
Arai T.
Watanabe T.
Masubuchi Y.
Horie T.
Suzuki T.
Ishikawa T.
Tsutsui M.
Kumagai Y.
Cho AK.
Chem. Res. Toxicol.
1997,
10:
289
1b
Bair KW.
Tuttle RL.
Knick VC.
Cory M.
McKee DD.
J. Med. Chem.
1990,
33:
2385
1c
Bair KW.
Andrews CW.
Tuttle RL.
Knick VC.
Cory M.
McKee DD.
J. Med. Chem.
1991,
34:
1983
2
Elliott AJ. In
Chemistry of Organic Fluorine Compounds II: A Critical Review
Hudlicky M.
Pavlath AE.
ACS Monograph 187, American Chemical Society;
Washington DC:
1995.
p.1119-1125
3a
Qiu XL.
Meng WD.
Qing FL.
Tetrahedron
2004,
60:
6711
3b
Sutherland A.
Willis CL.
Nat. Prod. Rep.
2000,
17:
621
3c
Kollonitsch J. In
Biomedicinal Aspects of Fluorine Chemistry
Filler R.
Kobayashi Y.
Elsevier;
Amsterdam:
1993.
4a Nagabhushan TL. inventors; US 4235892.
; Chem. Abstr. 1980, 94, 139433
4b
Wu G.
Schumacher DP.
Tormos W.
Clark JE.
Murphy BL.
J. Org. Chem.
1997,
62:
2996
4c
Stanek J.
Frei J.
Mett H.
Schneider P.
Regenass U.
J. Med. Chem.
1992,
35:
1339
4d Hennequin LFA, Gibson KH, and Foote KM. inventors; PCT Int. Appl. WO 2003047582 A1.
; Chem. Abstr. 2003, 139, 36516
5a
Bravo P.
Resnati G.
Zappala C.
J. Fluorine Chem.
1992,
59:
153
5b
Okada T.
Tsuji T.
Tsushima T.
Yoshida T.
Matsuura S.
J. Heterocycl. Chem.
1991,
28:
1061
5c
Foster AB.
Jarman M.
Kinas RW.
Van Maanen JMS.
Taylor GN.
Gaston JL.
Parkin A.
Richardson AC.
J. Med. Chem.
1981,
24:
1399
6a
De Kimpe N.
Jolie R.
De Smaele D.
J. Chem. Soc., Chem. Commun.
1994,
1221
6b
De Kimpe N.
De Smaele D.
Szakonyi Z.
J. Org. Chem.
1997,
62:
2448
6c
Abbaspour Tehrani K.
Van Nguyen T.
Karikomi M.
Rottiers M.
De Kimpe N.
Tetrahedron
2002,
58:
7145
6d
D’hooghe M.
Waterinckx A.
De Kimpe N.
J. Org. Chem.
2005,
70:
227
6e
D’hooghe M.
Rottiers M.
Jolie R.
De Kimpe N.
Synlett
2005,
931
7 As a representative example, the synthesis of 1-(3-methyl-benzyl)aziridin-2-ylmethyl 2-methylpropanoate 4a is described. To a solution of isobutyric acid (0.88 g, 1.0 equiv) in DMSO (15 mL) was added K2CO3 (2.76 g, 2 equiv), and the resulting suspension was stirred for 30 min at r.t. Subsequently, 2-(bromomethyl)-1-(3-methylbenzyl)-aziridine (3a, 2.40 g, 0.01 mol) was added, and the mixture was heated at 80 °C for 15 h. The reaction mixture was poured into H2O (20 mL) and extracted with Et2O (3 × 15 mL). The combined organic extracts were washed with H2O (2 × 15 mL) and brine (20 mL). Drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded 1-(3-methylbenzyl)aziridin-2-ylmethyl 2-methylpropanoate (4a), which was purified by filtration through silica gel (hexane-EtOAc, 5:3).
1-(3-Methylbenzyl)aziridin-2-ylmethyl 2-methylpropanoate (4a): R
f
= 0.25; light-yellow oil; yield 85%. 1H NMR (300 MHz, CDCl3): δ = 1.10 and 1.11 [6 H, 2 d, J = 6.9 Hz, (CH
3)2CH], 1.51 [1 H, d, J = 6.3 Hz, (H
cisCH)N], 1.77 [1 H, d, J = 3.3 Hz, (HCH
trans)N], 1.82-1.89 (1 H, m, NCH), 2.34 (3 H, s, CH3Ar), 2.47 [1 H, sept, J = 7.0 Hz, (CH3)2CH], 3.30 and 3.53 [2 H, 2 d, J = 13.3 Hz, N(HCH)Ar], 3.81 and 4.20 [2 H, 2 × dd, J = 11.6, 7.4, 4.5 Hz, (HCH)O], 7.06-7.24 (4 H, m, CHarom). 13C NMR (68 MHz, CDCl3): δ = 18.89 [(CH3)2CH], 21.39 (CH3Ar), 31.76 [(HcisCHtrans)N], 33.86 [(CH3)2
CH], 37.21 (CHN), 64.40 (NCH2Ar), 66.55 (CH2O), 125.14, 127.87, 128.27 and 128.85 (HCarom), 137.93 and 138.73 (2 × Carom,quat), 176.99 (CO). IR (NaCl): 1733 cm-1 (C=O). MS (70 eV): m/z (%) = 247 (19) [M+], 160 (38), 158 (17), 105 (100), 72 (21), 71 (38). Anal. Calcd for C15H21NO2: C, 72.84; H, 8.56; N, 5.66. Found: C, 72.97; H, 8.74; N, 5.50.
8a
Davoli P.
Forni A.
Moretti I.
Prati F.
Torre G.
Tetrahedron
2001,
57:
1801
8b
Davoli P.
Caselli E.
Bucciarelli M.
Forni A.
Torre G.
Prati F.
J. Chem. Soc., Perkin Trans. 1
2002,
1948
8c
Risberg E.
Fischer A.
Somfai P.
Tetrahedron
2005,
61:
8443
8d
Bilke JL.
Dzuganova M.
Fröhlich R.
Würthwein E.-U.
Org. Lett.
2005,
7:
3267
9a
Chang J.-W.
Bae JH.
Shin S.-H.
Park CS.
Choi D.
Lee WK.
Tetrahedron Lett.
1998,
39:
9193
9b
Sugiyama S.
Inoue T.
Ishii K.
Tetrahedron: Asymmetry
2003,
14:
2153
10a
D’hooghe M.
Van Brabandt W.
De Kimpe N.
J. Org. Chem.
2004,
69:
2703
10b
D’hooghe M.
Waterinckx A.
Vanlangendonck T.
De Kimpe N.
Tetrahedron
2006,
62:
2295
10c
D’hooghe M.
Van Speybroeck V.
Waroquier M.
De Kimpe N.
Chem. Commun.
2006,
1554
11 As a representative example, the synthesis of 3-[allyl-(3-methylbenzyl)amino]-2-bromopropyl 2-methylpropanoate (6a) is described. To a solution of 1-(3-methylbenzyl)-aziridin-2-ylmethyl 2-methylpropanoate (4a, 2.47 g, 10 mmol) in MeCN (50 mL) was added allyl bromide (1.45 g, 1.2 equiv) under stirring, and the resulting mixture was heated for 6 h under reflux. Evaporation of the solvent afforded 3-[allyl(3-methylbenzyl)amino]-2-bromopropyl 2-methylpropanoate (6a), which was purified by means of column chromatography (hexane-EtOAc, 49:1) on silica gel in order to obtain an analytically pure sample.
3-[Allyl(3-methylbenzyl)amino]-2-bromopropyl 2-methyl-propanoate (6a): colorless liquid; yield 90%; R
f
= 0.04 (hexane-EtOAc, 49:1). 1H NMR (300 MHz, CDCl3): δ = 1.17 [6 H, d, J = 7.2 Hz, (CH
3)2CH], 2.34 (3 H, s, CH3Ar), 2.54 [1 H, sept, J = 7.0 Hz, (CH3)2CH], 2.84 and 2.93 [2 H, 2 × dd, J = 13.7, 8.8, 5.9 Hz, N(HCH)CHBr], 3.06 and 3.17 [2 H, 2 × dd, J = 14.0, 6.9, 6.1 Hz, N(HCH)CH=CH2], 3.53 and 3.67 [2 H, 2 d, J = 13.5 Hz, N(HCH)Ar], 4.07-4.16 (1 H, m, CHBr), 4.27 and 4.50 [2 H, 2 × dd, J = 11.9, 6.3, 3.7 Hz, (HCH)O], 5.15-5.22 (2 H, m, CH=CH
2), 5.79-5.92 (1 H, m, CH=CH2), 7.05-7.26 (4 H, m, CHarom). 13C NMR (68 MHz, CDCl3): δ = 18.87 and 18.96 [(CH3)2CH], 21.41 (CH3Ar), 33.94 [(CH3)2
CH], 48.77 (CHBr), 57.50, 57.67 and 59.12 (3 × CH2N), 65.70 (CH2O), 118.07 (CH=CH2), 125.93, 127.95, 128.25 and 129.61 (HCarom), 135.23 (CH=CH2), 137.90 and 138.70 (2 × Carom,quat), 176.48 (CO). IR (NaCl): 1736 cm-1 (C=O). MS (70 eV): m/z (%) = 368, 370 (23) [M+ + 1], 288 (100) [M+ - Br]. Anal. Calcd for C18H26BrNO2: C, 58.70; H, 7.12; N, 3.80. Found: C, 58.91; H, 7.31; N, 3.66.
12 As a representative example, the synthesis of 2-[allyl(3-methylbenzyl)amino]-3-fluoropropyl 2-methylpropanoate (7a) and 3-[allyl(3-methylbenzyl)amino]-2-fluoropropyl 2-methylpropanoate (8a) is described. To a solution of 3-[allyl(3-methylbenzyl)amino]-2-bromopropyl 2-methyl-propanoate (6a, 3.68 g, 10 mmol) in MeCN (50 mL) was added TBAF·3H2O (4.73 g, 1.5 equiv) under stirring and the resulting mixture was heated for 7 h under reflux. Extraction with H2O (40 mL) and Et2O (3 × 30 mL), drying (MgSO4), filtration of the drying agent and evaporation of the solvent afforded a mixture of 2-[allyl(3-methylbenzyl)amino]-3-fluoropropyl 2-methylpropanoate (7a, 72%) and 3-[allyl(3-methylbenzyl)amino]-2-fluoropropyl 2-methylpropanoate (8a, 28%). Both isomers were separated by means of column chromatography (hexane-ethyl acetate, 34:1) in order to obtain analytically pure samples.
2-[Allyl(3-methylbenzyl)amino]-3-fluoropropyl 2-methyl-propanoate (7a): colorless liquid; R
f
= 0.16 (hexane-EtOAc, 34:1). 1H NMR (300 MHz, CDCl3): δ = 1.18 and 1.19 [6 H, 2 d, J = 6.9 Hz, (CH
3)2CH], 2.34 (3 H, s, CH3Ar), 2.57 [1 H, sept, J = 7.0 Hz, (CH3)2CH], 3.20-3.35 (3 H, m, CHN and NCH
2CH=CH2), 3.73 and 3.76 [2 H, 2 d, J = 14.3 Hz, N(HCH)Ar], 4.20 [1 H, dd, J = 11.4, 6.5 Hz, (HCH)O], 4.30 [1 H, ddd, J = 11.4, 6.5, 1.2 Hz, (HCH)O], 4.50 and 4.66 [2 H, dd, J = 47.5, 5.1 Hz, (HCH)F], 5.09-5.24 (2 H, m, CH=CH
2), 5.73-5.86 (1 H, m, CH=CH2), 7.04-7.32 (4 H, m, CHarom). 13C NMR (68 MHz, CDCl3): δ = 19.06 [(CH3)2CH], 21.52 (CH3Ar), 34.12 [(CH3)2
CH], 54.06 and 54.81 (2 × CH2N), 56.85 (d, J = 18.5 Hz, CHN), 61.55 (d, J = 5.8 Hz, CH2O), 82.34 (d, J = 171.9 Hz, CH2F), 117.28 (CH=CH2), 125.57, 127.82, 128.26 and 129.22 (HCarom), 136.84 (CH=CH2), 137.94 and 139.87 (2 × Carom,quat), 176.92 (CO). 19F (CCl3F): δ = -227.42 (td, J = 46.0, 22.4 Hz, CH2F). IR (NaCl): 1738 cm-1 (C=O). MS (70 eV): m/z
(%) = 307 (1) [M+], 274 (5) [M+ - CH2F], 206 (45), 174 (40), 105 (100). Anal. Calcd for C18H26FNO2: C, 70.33; H, 8.53; N, 4.56. Found: C, 70.50; H, 8.70; N, 4.41.
3-[Allyl(3-methylbenzyl)amino]-2-fluoropropyl 2-methyl-propanoate (8a): colorless liquid; R
f
= 0.09 (hexane-EtOAc, 34:1). 1H NMR (300 MHz, CDCl3): δ = 1.16 [6 H, d, J = 7.2 Hz, (CH
3)2CH], 2.34 (3 H, s, CH3Ar), 2.55 [1 H, sept, J = 7.0 Hz, (CH3)2CH], 2.74 (2 H, dd, J = 19.8, 5.5 Hz, NCH
2CHF), 3.15 (2 H, d, J = 6.3 Hz, NCH
2CH=CH2), 3.62 (2 H, s, NCH2Ar), 4.11-4.34 (2 H, m, CH2O), 4.76 (1 H, dddd, J = 48.8, 11.7, 5.8, 3.0 Hz, CHF), 5.14-5.23 (2 H, m, CH=CH
2), 5.85-5.93 (1 H, m, CH=CH2), 7.04-7.25 (4 H, m, CHarom). 13C NMR (68 MHz, CDCl3): δ = 18.92 [(CH3)2CH], 21.42 (CH3Ar), 33.88 [(CH3)2
CH], 53.39 (d, J = 23.1 Hz, NCH2CHF), 57.82 (NCH2CH=CH2), 59.13 (NCH2Ar), 64.42 (d, J = 21.9 Hz, CH2O), 90.33 (d, J = 173.1 Hz, CHF), 117.96 (CH=CH2), 125.95, 127.89, 128.22 and 129.61 (HCarom), 135.43 (CH=CH2), 137.90 and 138.83 (2 × Carom,quat), 176.80 (CO). 19F (CCl3F): δ = -189.50 to
-189.34 (m, CHF). IR (NaCl): 1736 cm-1 (C=O). MS
(70 eV): m/z (%) = 307 (3) [M+], 174 (99), 105 (100). Anal. Calcd for C18H26FNO2: C, 70.33; H, 8.53; N, 4.56. Found: C, 70.54; H, 8.72; N, 4.32.
13a
Pierre JL.
Baret P.
Rivoirard EM.
J. Heterocycl. Chem.
1978,
15:
817
13b
Bassindale AR.
Kyle PA.
Soobramanien MC.
Taylor PG.
J. Chem. Soc., Perkin Trans. 1
2000,
439
13c
Weber K.
Kuklinski S.
Gmeiner P.
Org. Lett.
2000,
2:
647
13d
Sim TB.
Kang SH.
Lee KS.
Lee WK.
Yun H.
Dong Y.
Ha H.-J.
J. Org. Chem.
2003,
68:
104
13e
Gnecco D.
Orea FL.
Galindo A.
Enríquez RG.
Toscano RA.
Reynolds WF.
Molecules
2000,
5:
998
13f
Crousse B.
Narizuka S.
Bonnet-Delpon D.
Begué J.-P.
Synlett
2001,
679
13g
Testa L.
Akssira M.
Zaballos-García E.
Arroyo P.
Domingo LR.
Sepúlveda-Arques J.
Tetrahedron
2003,
59:
677
13h
O’Brien P.
Towers TD.
J. Org. Chem.
2002,
67:
304
13i
Katagiri T.
Takahashi M.
Fujiwara Y.
Ihara H.
Uneyama K.
J. Org. Chem.
1999,
64:
7323
14a
Wade TN.
J. Org. Chem.
1980,
45:
5328
14b
Alvernhe GM.
Ennakoua CM.
Lacombe SM.
Laurent AJ.
J. Org. Chem.
1981,
46:
4938
14c
Alvernhe GM.
Lacombe S.
Laurent A.
Tetrahedron Lett.
1980,
21:
289